Amitriptyline is a tricyclic antidepressant used to treat depression and neuropathic pain. It helps restore the balance of certain natural chemicals in the brain like serotonin and norepinephrine.
The global Amitriptyline Market is estimated to be valued at US$ 699.27 Mn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
The amitriptyline market has witnessed significant growth owing to the increasing prevalence of depression globally. Amitriptyline is a tricyclic antidepressant (TCA) that is used primarily for the treatment and management of major depressive disorders. It works by increasing the levels of serotonin and norepinephrine in the brain. The increasing cases of depression and other mood disorders has augmented the demand for amitriptyline as it is one of the most commonly prescribed medications ... Read more
